Leidos Partnership Deploys MHS GENESIS Overseas In First Of Two Planned OCONUS Waves
Portfolio Pulse from Benzinga Newsdesk
Leidos Partnership for Defense Health (LPDH) has successfully deployed the MHS GENESIS electronic health record to an additional 9,000 Department of Defense (DOD) clinicians and providers as part of its first Outside of the Contiguous United States (OCONUS) deployment. The current system deployment spans 10 Military Treatment Facilities (MTFs) across Europe and the United Kingdom. LPDH also deployed MHS GENESIS to users at Fort Buchanan, Puerto Rico and Guantanamo Bay, Cuba. The system is now operational at over 3,500 locations and reaches over seven million DOD beneficiaries.
October 17, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Leidos' successful deployment of the MHS GENESIS electronic health record to additional DOD clinicians and providers in its first OCONUS deployment could potentially boost the company's reputation and increase its market share in the defense health sector.
The successful deployment of the MHS GENESIS electronic health record to additional DOD clinicians and providers in its first OCONUS deployment demonstrates Leidos' capabilities in the defense health sector. This could potentially boost the company's reputation and increase its market share, which could have a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100